A new analysis in Clinical Gastroenterology and Hepatology (Brenner et al., Sept 2025) examines geodemographic trends in private equity (PE) acquisitions of U.S. gastroenterology practices from 2013–2023. The study confirms that GI has become a prime target for PE investment, driven by its high-volume procedures, strong ancillary revenue streams, and outpatient consolidation opportunities. What was once an abstract trend is now local and visible, directly shaping daily GI practice across the country. The findings underscore how PE is reshaping practice ownership and care delivery in gastroenterology.
Trending
- Inside the 600+ member WhatsApp group where no topic is taboo
- Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity (National Comprehensive Cancer Network)
- Physician Fee Schedule 2027: What physicians need to know now (Medical Economics)
- Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer (Business Wire)
- What Happens to Independent Medicine When Private Equity Shows Up With a Checkbook (MedCity News)
- AGA launches AI-powered virtual assistant for gastroenterology and hepatology care (News Medical)
- AMSURG Acquires 5 Endoscopy Centers in North Carolina (ASC News)
- Hawaii mandates free follow-up colonoscopies, wipes $91M in medical debt (Becker’s Healthcare)
